Ph-Negative Chronic Myeloid Leukemia: The Nature of the Breakpoint Junctions and Mechanism of ABL Transposition

References

• Nowell P. C., Hungerford D. A. A minute chromosome in chronic granulocytic leukemia. Science 1960; 132: 1497
   Web of Science ®Google Scholar
• Morris C. M., Fitzgerald P. H., Hollings P. E., Archer S. A., Rosman I., Beard M. E. J., Heaton D. C., Newhook C. J. Essential thrombocythaemia and the Philadelphia chromosome. British Journal of Haemaiology 1988; 70: 13–19
   PubMed Web of Science ®Google Scholar
• Kurzrock R., Shtalrid M., Talpaz M., Kloetzer W. S., Gutterman J. U. Expression of c-abl in Philadelphia-positive acute myelogenous leukemia. Blood 1987; 70: 1584–1588
   PubMed Web of Science ®Google Scholar
• Fitzgerald P. H., Morris C. M. The variable hematologic expression of the BCR-ABL genomic mutation and its possible determinants. Cancer Genetics and Cytogenetics 1989; 42: 9–25
   PubMed Web of Science ®Google Scholar
• Rowley J. D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa stainin. Nature 1973; 243: 290–293
   PubMed Web of Science ®Google Scholar
• Morris C. M., Heisterkamp N., Groffen J., Fitzgerald P. H. Entire ABL gene is joined with 5′-BCR in some patients with Philadelphia-positive leukemia. Blood 1991; 78: 1078–1084
   PubMed Web of Science ®Google Scholar
• Heisterkamp N., Jenster G., ten Hoeve J., Zovich D., Pattengale P. K., Groffen J. Acute leukaemia in bcr/abl transgenic mice. Nature 1990; 344: 251–253
   PubMed Web of Science ®Google Scholar
• Daley G. Q., Van Etten R. A., Baltimore D. Induction of chronic myelogenous leukemia in mice by the p210bcr/abl gene of the Philadelphia chromosome. Science 1990; 247: 824–830
   PubMed Web of Science ®Google Scholar
• Kelliher M. A., McLaughlin J., Witte O. N., Rosenberg N. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proceedings of the National Academy of Sciences U.S.A. 1990; 87: 6649–6653
   PubMed Web of Science ®Google Scholar
• Travis L. B., Pierre R. V., De Wald G. W. Ph1 negative chronic granulocytic leukemia: a non-entity. American Journal of Clinical Pathology 1986; 85: 186–193
   PubMed Web of Science ®Google Scholar
• Pugh W. C., Pearson M., Vardiman J. W., Rowley J. D. Philadelphia chromosome negative chronic myelogenous leukaemia: a morphological reassessment. British Journal of Haematology 1985; 60: 457–467
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Morris C. M., Reeve A. E., Fitzgerald P. H., Hollings P. E., Beard M. E. J., Heaton D. C. Genomic diversity correlates with clinical variation in Ph1-negative chronic myeloid leukaemia. Nature 1986; 320: 281–283
   PubMed Web of Science ®Google Scholar
• Fitzgerald P. H., Beard M. E. J., Morris C. M., Heaton D. C., Reeve A. E. Ph-negative chronic myeloid leukaemia. British Journal of Haematology 1987; 66: 311–314
   PubMed Web of Science ®Google Scholar
• Kurzrock K., Kantarjian H. M., Shtalrid M., Gutterman J. U., Talpaz M. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course. Blood 1990; 75: 445–452
   PubMed Web of Science ®Google Scholar
• Westbrook C. A., Hooberman A. L., et al. A study of 58 consecutive adults with ALL entered on CALB treatment protocols. 1991, (personal communication)
   Google Scholar
• Dreazen O., Klisak I., Rassool F., Goldman J. M., Sparkes R. S., Gale R. P. Do oncogenes determine clinical features in chronic myeloid leukaemia. The Lancet 1987; 2: 1402–1405
   Google Scholar
• Ganesan T. S., Rassool F., Guo A-P., Th'ng K. H., Dowding C., Hibbin J. A., Young B. D., White H., Kumaran T. O., Galton D. A. G., Goldman J. M. Rearrangement of the bcr gene in Philadelphia chromosome-negative chronic myeloid leukemia. Blood 1986; 68: 957–960
   PubMed Web of Science ®Google Scholar
• Kurzrock R., Blick M. B., Talpaz M., Velasquez W. S., Trujillo J. M., Kouttab N. M., Kloetzer W. S., Arlinghaus R. B., Gutterman J. U. Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia. Annals of Internal Medicine 1986; 105: 673–679
   PubMed Web of Science ®Google Scholar
• Morris C. M., Heisterkamp N., Kennedy M. A., Fitzgerald P. H., Groffen J. Ph-negative chronic myeloid leukemia: molecular analysis of ABL insertion into M-BCR on chromosome 22. Blood 1990; 9: 1812–1818
   Google Scholar
• Bernard A., Rubin C. M., Westbrook C. A., Paskind M., Baltimore D. The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia. Molecular and Cellular Biology 1987; 7: 3231–3236
   PubMed Web of Science ®Google Scholar
• Westbrook C. A., Rubin C. M., Carrino J. J., Le Beau M. M., Bernards A., Rowley J. D. Long-range mapping of the Philadelphia chromosome by pulsed-field gel electrophoresis. Blood 1988; 71: 697–702
   PubMed Web of Science ®Google Scholar
• Rassool F., Martiat P., Taj A., Klisak L., Goldman J. Interstitial insertion of varying amounts of ABL-containing genetic material into chromosome 22 in Ph-negative CML. Leukemia 1990; 4: 273–277
   PubMed Web of Science ®Google Scholar
• Sharp P. A. Conversion of RNA to DNA in mammals: Alu-WVe elements and pseudogenes. Nature 1983; 301: 471–472
   PubMed Web of Science ®Google Scholar
• Weiner A. M., Deininger P. L., Efstratiadis A. Nonviral retroposons: genes, pseudogenes, and transposable elements generated by the reverse flow of genetic information. Annual Review of Biochemistry 1986; 55: 631–661
   PubMed Web of Science ®Google Scholar
• Baltimore D. Retroviruses and retrotransposons: the role of reverse transcription in shaping the eukaryotic genome. Cell 1985; 40: 481–482
   PubMed Web of Science ®Google Scholar
• Groffen J., Morris C. M., Heisterkamp N. Philadelphia chromosome translocation. Chronic Myelogenous Leukemia, Molecular Approach to Research and Therapy, A. Deisseroth, R. B. Arlinghaus. Marcel Dekker, New York 1991; 181–207
   Google Scholar
• van der Plas D. C., Hermans A. B. C., Soekarman D., Smith E. M. E., de Klein A., Smadja N., Alimena G., Goudsmit R., Grozveld G., Hagemeijer A. Cytogenetic and molecular analysis in Philadelphia negative CML. Blood 1989; 73: 1038–1044
   PubMed Web of Science ®Google Scholar
• Morris C., Kennedy M., Heisterkamp N., Columbano-Green L., Romeril K., Groffen J., Fitzgerald P. A complex chromosome rearrangement forms the BCR-ABL fusion gene in leukemic cells with a normal karyotype. Genes Chromosomes and Cancer 1991; 3: 263–271
   PubMed Web of Science ®Google Scholar
• Bartram C. R., Kleihauer E., de Klein A., Grosveld G., Teyssier J. R., Heisterkamp N., Grof Ten J. C-abl, her are rearranged in a Ph1-negative CML patient. EMBO Journal 1985; 4: 683–686
   PubMed Web of Science ®Google Scholar
• Hagemeijer A., Bartram C. R., Smith E. M. E., van Agthoven A. J., Bootsma D. Is the chromosomal region 9q34 always involved in the variants of the Ph translocation. Cancer Genetics and Cytogenetics 1984; 13: 1–16
   PubMed Web of Science ®Google Scholar
• Hagemeijer A., de Klein A., Godde-Salz E., Turc-Carel C., Smith E. M. E., van Agthoven A. J., Grosveld G. C. Translocation of c-abl to “masked” Ph in chronic myeloid leukemia. Cancer Genetics and Cytogenetics 1985; 18: 95–104
   PubMed Web of Science ®Google Scholar
• Morris C. M., Rosman I., Archer Cochrane S. A. J. M., Fitzgerald P. H. A cytogenetic and molecular analysis of five variant Philadelphia translocations in chronic myeloid leukemia. Cancer Genetics and Cytogenetics 1988; 35: 179–197
   PubMed Web of Science ®Google Scholar
• Heim S., Mitelman F. Cancer Cytogenetics. Alan R. Liss, Inc., New York 1987; 47–51
   Google Scholar
• Sandberg A. A. The Chromosomes in Human Cancer and Leukemia., 2nd edn. Elsevier, New York 1990; 519–520
   Google Scholar
• Weidermann L. M., Karhi K. K., Shivji M. K. K., Rayter S I., Pegram S. M., Dowden G., Bevan D., Will A., Galton D. A. G., Chan L. C. The correlation of breakpoint cluster region rearrangement and p210phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases. Blood 1988; 71: 349–355
   PubMed Web of Science ®Google Scholar
• Inazawa J., Nishigaki H., Takahira H., Nichimura J., Horiike S., Taniwaki M., Misawa S., Abe T. Rejoining between 9q+ and Philadelphia chromosomes results in normal-looking chromosomes 9 and 22 in Ph1-negative chronic myelocytic leukemia. Human Genetics 1989; 83: 115–118
   PubMed Web of Science ®Google Scholar
• Ishihara T., Minamihisamatus M. The Philadelphia chromosome. Considerations based on studies of variant Ph translocations. Cancer Genetics and Cytogenetics 1988; 32: 75–92
   PubMed Web of Science ®Google Scholar
• Fitzgerald P. H., Morris C. M. Complex chromosomal translocations in the Philadelphia chromosome leukemias: serial translocations or a concerted genomic rearrangement?. Cancer Genetics and Cytogenetics, (in press)
   Web of Science ®Google Scholar
• Haluska F. G., Tsujimoto Y., Croce C. M. Oncogene activation by chromosome translocation in human malignancy. Annual Review of Genetics 1987; 21: 321–345
   PubMed Web of Science ®Google Scholar
• Huebner K., Nowell P. C., Croce C. M. Lineage-specific gene rearrangement/deletion: a nonconserva-tive model. Cancer Research 1989; 49: 4071–4074
   PubMed Web of Science ®Google Scholar
• Heisterkamp N., Stam K., Groffen J., de Klein A., Grosveld G. Structural organization of the bcr gene and its role in the Ph1 translocation. Nature 1985; 315: 758–761
   PubMed Web of Science ®Google Scholar
• Heisterkamp N., Groffen J. Oncogene chromosome breakpoints and Alu sequences. Nature 1985; 317: 559
   PubMed Web of Science ®Google Scholar
• de Klein A., van Agthoven T., Groffen C., Heisterkamp N., Groffen J., Grosveld G. Molecular analysis of both translocation products of a Philadelphia-positive CML patient. Nucleic Acids Research 1986; 14: 7071–7081
   PubMed Web of Science ®Google Scholar
• van der Feltz M. J. M., Shivji M. K. K., Allen P. B., Heisterkamp N., Groffen J., Wiedemann L. M. Nucleotide sequence of both reciprocal translocation junction regions in a patient with Ph positive acute lymphoblastic leukaemia, with a breakpoint within the first intron of the BCR gene. Nucleic Acids Research 1989; 17: 1–10
   PubMed Web of Science ®Google Scholar
• Chen S. J., Chen Z., d'Auriol L., Le Coniat M., Grausz D., Berger R. Ph1bcr-acute leukemias: implication of Alu sequences in a chromosomal translocation occurring in the new cluster region within the BCR gene. Oncogene 1989; 4: 195–202
   PubMed Web of Science ®Google Scholar
• Papadopoulos P. C., Greenstein A. M., Gaffney R. A., Westbrook C. A., Weidermann L. M. Characterization of the translocation breakpoint sequences in Philadelphia-positive acute lymphoblastic leukemia. Genes Chromosomes Cancer 1990; 1: 233–239
   PubMed Web of Science ®Google Scholar
• Vanin E. F., Henthron P. S., Koussis D., Grosveld F., Smithies O. Unexpected relationships between four large deletions in the human β-globin gene cluster. Cell 1983; 35: 701–709
   PubMed Web of Science ®Google Scholar
• Lehrman M. A., Schneider W. J., Sudhof T. C., Brown M. S., Goldstein J. L., Russell O. W. Mutations in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains. Science 1985; 227: 140–146
   PubMed Web of Science ®Google Scholar
• Stoppa-Lyonnet D., Carter P. E., Meo T., Tosi M. Clusters of intragenic Alu repeats predispose the human Cl inhibition locus to deleterious rearrangements. Proceedings of the National Academy of Sciences USA 1990; 87: 1551–1555
   PubMed Web of Science ®Google Scholar
• Evans H. J. Molecular mechanisms in the induction of chromosome aberrations. Progress in Genetic Toxicology, D. Scott, B. A. Bridges, F. H. Sobels. Elsevier/North Holland, Amsterdam 1977; 57–74
   Google Scholar
• Ames B. N. Background levels of DNA damage in the population. Basic Life Sciences 1986; 38: 529–535
   PubMedGoogle Scholar
• Floyd R. A. Role of oxygen free radicals in carcinogenesis and brain ischemia. Federation of American Societies for Experimental Biology Journal 1990; 4: 2587–2597
   PubMed Web of Science ®Google Scholar
• Ames B. N. Mutagenesis and carcinogenesis: endogenous and exogenous factors. Environmental and Molecular Mutagenesis 1989; 14(Supplement 16)66–77
   PubMed Web of Science ®Google Scholar
• Fredga K., Reitalu J., Berlin M. Chromosome studies in workers exposed to benzene. Genetic Damage in Man Caused by Environmental Agents, K. Berg. Academic Press, New York 1979; 187–203
   Google Scholar
• Preston R. J. A short journey from classical to molecular cytogenetics. Environmental and Molecular Mutagenesis 1989; 14: 126–132
   PubMed Web of Science ®Google Scholar
• Scott D., Batchelor A. L., Sharpe H., Evans H. J. RBE for fast neutrons and dose rate studies using fast neutron irradiation. Human Radiation Cytogenetics, H. J. Evans, W. M. Court, A. S. Brown. North Hollandg, Amsterdam 1967; 37–52, McLean
   Google Scholar
• Holmberg M. The effects of recoiling oxygen nuclei on the frequency of chromosome breakage in human lymphocytes after fast neutron irradiation. Mutagen-induced Chromosome Damage in Man, H. J. Evans, D. C. Lloyd. University Press, Edinburgh 1978; 14–21
   Google Scholar
• Gunz F. W., Henderson E. S. Leukemia, 4th edn. Grune and Stratton, New York 1983; 359–374
   Google Scholar